However, before adding anything new to your regimen, though, consult your healthcare professional to make sure it is safe for you
A decrease in the expression of the pro-ferroptotic proteins ACSL4, TFR1, and VDAC2/3 and a decrease in dihydroethidium (DHE) fluorescence, iron, malondialdehyde (MDA), and myeloperoxidase (MPO) were further observed in metformin-treated mice
The combination addresses both insulin resistance (metformin) and appetite signaling dysfunction (GLP-1), creating complementary metabolic benefits for patients with obesity and type 2 diabetes
Certainly await the full study results of the COURAGE trial by Regeneron but seems like were on the verge of being able to address what is likely the most concerning long-term side effects of GLP1
It protects cells against oxidative stress, supports immunity and helps the liver do its work
PMID 8558223